Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults

AIDS Research and Human Retroviruses

Volumn 16, Issue 8, 2000, Pages 807-813

  Becker Pergola, G ^a   Kataaha, P ^b   Johnston Dow, L ^c   Fung, S ^c   Jackson, J B ^a   Eshleman, S H ^a,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Department of Molecular Genetics   (Uganda)

^c APPLIED BIOSYSTEMS   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UGANDA; VIRUS CHARACTERIZATION; VIRUS RECOMBINATION;

ADULT; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; UGANDA;

EID: 0034690720     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200308800     Document Type: Article

References (15)

1. 1. Brennan CA, Lund JK, Golden A, Yamaguchi J, Vallari AS, Phillips JF, Kataaha PK, Jackson JB, and Devare SG: Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda. AIDS 1997;11:1823-1832.
2. 2. Rayfield MA, Downing RG, Baggs J, Hu DJ, Pieniazek D, Luo CC, Biryahwaho B, Otten RA, Sempala SDK, and Dondero TJ: A molecular epidemiologic survey of HIV in Uganda. HIV Variant Working Group. AIDS 1998;12:521-527.
3. 3. Kaleebu P, Bobkov A, Cheingsong-Popov R, Bieniasz P, Garaev M, and Weber J: Identification of HIV-1 subtype G from Uganda. AIDS Res Hum Retroviruses 1995;11:657.
4. 4. Mellquist JL, Bowman B, Kasturi L, Guay L, Kataaha P, Mmiro F, Ndguwa C, Jackson JB, and Eshleman SH: Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants. AIDS Res Hum Retroviruses 1998;14:1391-1395.
5. 5. Brodine SK, Mascola JR, Weiss PJ, Ito SI, Porter KR, Artenstein AW, Garland PC, McCutchan FE, and Burke DS: Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346: 1198-1199.
6. 6. Gao F, Yue L, Hill SC, Robertson DL, Graves AH, Saag MS, Shaw GM, Sharp PM, and Hahn BH: HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses 1994;10:625-627.
7. 7. Beatrice ST, Oleszko WR, Punsalang A, Chaisson MA, Torian LV, Schable CA, and Weisfuse IB: HIV-2 and non-B subtypes of HIV-1 group M in specimens submitted to the New York City (NYC) Department of Health Retrovirology Laboratory from 1993-1997. In: 12th World AIDS Conference, Geneva, Switzerland, 1998. [Abstract 42116]
8. 8. Irwin KL, Pau CP, Lupo D, Pienazek D, Luo CC, Olivo N, Rayfield M, Hu DJ, Weber JT, Respess RA, Janssen R, Minor P, and Ernst J: Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: A sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention -Bronx Lebanon HIV Serosurvey Team. J Infect Dis 1997; 176:1629-1633.
9. 9. Weidle PJ, Ganea CE, Pienniazek D, Ramos A, Schable CA, Ernst J, and McGowan J: Prevalence of HIV-1 group M, non-B subtypes in a Bronx New York community: A sentinel site for monitoring HIV genetic diversity in the United States. In: 12th World AIDS Conference, Geneva, Switzerland, 1998. [Abstract 13225]
10. 10. Mellquist JL, Becker-Pergola G, Gu J, Guay L, Himes L, Kataaha P, Mmiro F, Ndugwa C, Jackson JB, and Eshleman SH: Dual transmission of subtype A and D HIV-1 viruses from a U gandan woman to her infant. AIDS Res Hum Retroviruses 1999;15:217-221.
11. 11. Korber B, Kuiken C, Foley B, Hahn B, McCutchan F, Mellors J, and Sodroski J: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1998.
12. 12. Koch N, Yahi N, Colson P, Fantini J, and Tamalet C: Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. J Virol Methods 1999;80:25-31.
13. 13. Puchhammer-Stockl E, Schmied B, Mandl CW, Vetter N, and Heinz FX: Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance. J Med Virol 1999;57:283-289.
14. 14. Vahey M, Nau ME, Barrick S, Cooley JD, Sawyer R, Sleeker AA, Vickerman P, Bloor S, Larder B, Michael NL, and Wegner SA: Performance of the affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol 1999;37:2533-2537.
15. 15. Huang D, Polstra D, Geisler T, Scianna S, Bremer J, Robb M, Michael N, Brun-Vezinet F, and Reichelderfer P: Characterization of an international HIV-1 subtype panel for future use as standards and reference strains. In: 6th Conf. on Retroviruses and Opportunistic Infections, Chicago, Illinois, 1999. [Abstract 719]